K. Nordstrom and M. Allen, Managing the acutely agitated and psychotic patient. CNS Spectr, 2007.

J. Guelfi and A. Psychiatric-association, DSM-IV : manuel diagnostique et statistique des troubles mentaux. 4 éd, 1996.

V. Bourdinaud and F. Pochard, Enquête sur la prise en charge des patients en état d'agitation dans les services d'accueil et d'urgences en France, Encephale. Avr, vol.29, issue.2, pp.89-98, 2003.

P. Thomas, Acceptabilité en début de traitement. L'Encéphale, pp.78-80, 200712.

J. Battaglia, Abstract, CNS Spectrums, vol.5, issue.S11, pp.4-5, 2007.
DOI : 10.1016/S0893-133X(01)00365-7

F. Moritz, F. Bauer, A. Boyer, P. Lemarchand, J. Kerleau et al., Les patients agités au service d'accueil et d'urgence du CHU de Rouen, Presse Med, vol.28, issue.30, pp.1630-1634, 1999.

B. Zoupanos and C. Bryois, Traitement de l'agitation aux urgences somatiques, Rev Med Suisse, 2005.

H. Allain, O. Zekri, S. Schuck, and D. Bentue-ferrer, Benzodiazepines et/ou neuroleptiques dans le traitement de l'agitation du sujet âgé. Revue fr psychiatr psychol méd, Avr, vol.7, pp.155-158, 1997.

G. Fricchione, S. Nejad, J. Esses, T. Cummings, J. Querques et al., Postoperative Delirium, American Journal of Psychiatry, vol.165, issue.7, pp.803-812, 2008.
DOI : 10.1176/appi.ajp.2008.08020181

R. Bourne, T. Tahir, M. Borthwick, and E. Sampson, Drug treatment of delirium: Past, present and future, Journal of Psychosomatic Research, vol.65, issue.3, pp.273-282, 2008.
DOI : 10.1016/j.jpsychores.2008.05.025

G. Brousse, A. Taulemesse, V. Boute-makota, P. Llorca, and J. Schmidt, Place des neuroleptiques atypiques dans le traitement des états d'agitation chez l'adulte. Médecine thérapeutique, Fév, vol.11, issue.1, pp.38-44, 2005.

C. Pull, O. Mondiale-de, and L. Santé, Classification Internationale des Maladies -Dixième révision -Chapitre V (F) : troubles mentaux et troubles du comportement : descriptions cliniques et directives pour le diagnostic, 1993.

D. Robinson, Evaluation of acute agitation. CNS Spectr, Aoû, vol.12, issue.8 11, pp.6-7, 2007.

H. Autorité and D. Santé, Confusion aiguë chez la personne âgée : prise en charge initiale de l'agitation. Recommandations de bonne pratique, 2009.

F. Moritz, J. Jenvrin, S. Canivet, and D. Gerault, Conduite à tenir devant une agitation aux urgences. Réanimation, pp.500-506, 2004.

N. Bazin, Diagnostic des états d'agitation des sujets âgés. La revue de gériatrie, pp.451-456, 2002.

F. Petitjean and V. Siari, Les états d'agitation dans les services d'urgences : modalités thérapeutiques, Ann méd psychol, vol.160, issue.2, pp.193-196, 2002.

M. Allen, G. Currier, D. Carpenter, R. Ross, and J. Docherty, Introduction: Methods, Commentary, and Summary, Journal of Psychiatric Practice, vol.11, issue.Supplement 1, pp.5-108, 2005.
DOI : 10.1097/00131746-200511001-00002

M. Miller, Evaluation and management of delirium in hospitalized older patients. Am Fam Physician, Déc, vol.178, issue.11, pp.1265-1270, 2008.

P. Bourrier, N. Derouet, and S. Saci, Traitement de l'agitation de l'adulte en service d'urgence. JEUR, pp.212-218, 2003.

. American-psychiatric-association, Practice Guideline for the Treatment of Patients With Delirium, Am J Psychiatry. Mai, vol.156, issue.5, pp.1-20, 1999.
DOI : 10.1176/appi.books.9780890423363.42494

B. Pun and E. Ely, The importance of diagnosing and managing ICU delirium. Chest, 2007.

J. Chevrolet and P. Jolliet, Clinical review: Agitation and delirium in the critically ill ??? significance and management, Critical Care, vol.11, issue.3, p.214, 2007.
DOI : 10.1186/cc5787

L. Citrome, Interventions for the treatment of acute agitation. CNS Spectr, Aoû, vol.12, issue.8, pp.8-12, 2007.

D. Rund, J. Ewing, K. Mitzel, and N. Votolato, The use of intramuscular benzodiazepines and antipsychotic agents in the treatment of acute agitation or violence in the emergency department, The Journal of Emergency Medicine, vol.31, issue.3, pp.317-324, 2006.
DOI : 10.1016/j.jemermed.2005.09.021

G. Currier, M. Allen, E. Bunney, D. Daniel, A. Francis et al., Intramuscular antipsychotics: Clinical experience review, The Journal of Emergency Medicine, vol.27, issue.4, pp.3-4, 2004.
DOI : 10.1016/j.jemermed.2004.08.010

C. Lazignac, B. Ricou, L. Dan, S. Virgillito, E. Adam et al., Prise en charge pharmacologique des états d'agitation aux soins intensifs: intérêt des guides cliniques psychiatriques? Rev Med Suisse, Fév, vol.143, issue.98, pp.414-419, 2007.

R. Prescrire, Patients sous neuroleptique. Rev Prescrire, Déc Interactions Médicamenteuses), vol.28, issue.302, pp.194-198, 2008.

M. Mayo-smith, L. Beecher, T. Fischer, D. Gorelick, J. Guillaume et al., Management of alcohol withdrawal delirium. An evidence-based practice guideline, Arch. Intern. Med Jul, vol.12164, issue.13, pp.1405-1412, 2004.

R. Prescrire, Patients insomniaques. Rev Prescrire, Déc Interactions Médacamenteuses), vol.28, issue.302, pp.212-215, 2008.

E. Lonergan, J. Luxenberg, A. Sastre, A. Wyller, and T. , Benzodiazepines for delirium, Cochrane Database Syst Rev, issue.1, p.6379, 2009.

E. Lonergan, A. Britton, J. Luxenberg, and T. Wyller, Antipsychotics for delirium, Cochrane Database Syst Rev, issue.2, p.5594, 2007.

C. Ballard and J. Waite, The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease, Cochrane Database Syst Rev, issue.1, p.3476, 2006.

G. Alexopoulos, J. Streim, D. Carpenter, and J. Docherty, Using antipsychotic agents in older patients, J Clin Psychiatry, vol.65, issue.2, pp.5-99, 2004.

P. Bedouch, B. Allenet, and C. J. , iatrogénie médicamenteuse : quels enjeux pour la pharmacie clinique? Dans: Pharmacie Clinique et Thérapeutique, pp.9-18, 2008.

P. Michel, J. Quenon, A. Djihoud, S. Tricaud-vialle, A. Sarasqueta et al., Les événements indésirables graves liés aux soins observés dans les établissements de santé : premiers résultats d'une étude nationale (Enquête ENEIS), DRESS Etudes et Résultats, issue.398, pp.1-16, 2005.

H. Autorité and D. Santé, Legrain S. Consommation Médicamenteuse chez le Sujet Agé : Consommation, Prescription Available from, Iatrogénie et Observance [Internet], 2005.

P. Routledge, O. Mahony, M. Woodhouse, and K. , Adverse drug reactions in elderly patients, British Journal of Clinical Pharmacology, vol.54, issue.Suppl 6, pp.121-126, 2004.
DOI : 10.1046/j.1365-2125.2003.01875.x

S. Handler, R. Wright, C. Ruby, and J. Hanlon, Epidemiology of medication-related adverse events in nursing homes, The American Journal of Geriatric Pharmacotherapy, vol.4, issue.3, pp.264-272, 2006.
DOI : 10.1016/j.amjopharm.2006.09.011

J. Gurwitz, T. Field, J. Avorn, D. Mccormick, S. Jain et al., Incidence and preventability of adverse drug events in nursing homes, The American Journal of Medicine, vol.109, issue.2, pp.87-94, 2000.
DOI : 10.1016/S0002-9343(00)00451-4

K. Alagiakrishnan and C. Wiens, An approach to drug induced delirium in the elderly. Postgraduate Medical Journal, pp.388-393, 2004.

A. Moore, O. Keeffe, and S. , Drug-induced cognitive impairment in the elderly. Drugs Aging, 1999.

N. Campbell, M. Boustani, T. Limbil, C. Ott, C. Fox et al., The cognitive impact of anticholinergics: a clinical review, Clin Interv Aging, vol.4, pp.225-233, 2009.

T. Saïas and T. Gallarda, R??actions d???agressivit?? sous benzodiaz??pines??: une revue de la litt??rature, L'Enc??phale, vol.34, issue.4, pp.330-336, 2008.
DOI : 10.1016/j.encep.2007.05.005

H. Autorité and D. Santé, Améliorer la prescription des psychotropes chez le sujet âgé. Propositions d'actions concertées. [Internet] Available from, 2007.

R. Prescrire, Patients âgés déments et neuroleptiques : excès de mortalité. Rev Prescrire, Juin, vol.30, issue.320, pp.427-436, 2010.

P. Wang, S. Schneeweiss, J. Avorn, M. Fischer, H. Mogun et al., Risk of Death in Elderly Users of Conventional vs. Atypical Antipsychotic Medications, New England Journal of Medicine, vol.353, issue.22, pp.2335-2341, 2005.
DOI : 10.1056/NEJMoa052827

S. Gill, S. Bronskill, S. Normand, G. Anderson, K. Sykora et al., Antipsychotic Drug Use and Mortality in Older Adults with Dementia, Annals of Internal Medicine, vol.146, issue.11, pp.775-786, 2007.
DOI : 10.7326/0003-4819-146-11-200706050-00006

R. Aparasu, E. Jano, M. Johnson, and H. Chen, Hospitalization risk associated with typical and atypical antipsychotic use in community-dwelling elderly patients, The American Journal of Geriatric Pharmacotherapy, vol.6, issue.4, 2008.
DOI : 10.1016/j.amjopharm.2008.10.003

A. Glassman and J. Bigger, Antipsychotic Drugs: Prolonged QTc Interval, Torsade de Pointes, and Sudden Death, American Journal of Psychiatry, vol.158, issue.11, pp.1774-1782, 2001.
DOI : 10.1176/appi.ajp.158.11.1774

C. Gury, O. Canceil, and P. Iaria, Antipsychotiques et sécurité cardio-vasculaire : données actuelles sur les allongements de l'intervalle QT et le risque d'arythmies ventriculaires, Encephale, 2000.

N. Herrmann, M. Mamdani, and K. Lanctôt, Atypical Antipsychotics and Risk of Cerebrovascular Accidents, American Journal of Psychiatry, vol.161, issue.6, pp.1113-1115, 2004.
DOI : 10.1176/appi.ajp.161.6.1113

S. Gill, P. Rochon, N. Herrmann, P. Lee, K. Sykora et al., Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study, BMJ, vol.330, issue.7489, p.445, 2005.
DOI : 10.1136/bmj.38330.470486.8F

R. Leipzig, R. Cumming, and M. Tinetti, Drugs and Falls in Older People: A Systematic Review and Meta-analysis: I. Psychotropic Drugs, Journal of the American Geriatrics Society, vol.351, issue.suppl, pp.30-39, 1999.
DOI : 10.1111/j.1532-5415.1999.tb01898.x

R. Prescrire, Les médicaments injectables pour l'agitation aiguë chez un adulte non coopérant, Rev Prescrire, vol.23, issue.243, pp.688-92, 2003.

D. Vinkers, J. Gussekloo, R. Van-der-mast, F. Zitman, and R. Westendorp, Benzodiazepine Use and Risk of Mortality in Individuals Aged 85 Years or Older, JAMA: The Journal of the American Medical Association, vol.290, issue.22, pp.2942-2943, 2003.
DOI : 10.1001/jama.290.22.2942

W. Ray, M. Griffin, and W. Downey, Benzodiazepines of long and short elimination half-life and the risk of hip fracture, JAMA Déc, vol.15262, issue.23, pp.3303-3307, 1989.

A. Wagner, F. Zhang, S. Soumerai, A. Walker, J. Gurwitz et al., Benzodiazepine Use and Hip Fractures in the Elderly, Archives of Internal Medicine, vol.164, issue.14, pp.1567-1572, 2004.
DOI : 10.1001/archinte.164.14.1567

R. Herings, B. Stricker, A. De-boer, A. Bakker, and F. Sturmans, Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life, Archives of Internal Medicine, vol.155, issue.16, pp.1801-1807, 1995.
DOI : 10.1001/archinte.155.16.1801

M. Barker, K. Greenwood, M. Jackson, and S. Crowe, Cognitive Effects of Long-Term Benzodiazepine Use, CNS Drugs, vol.29, issue.1, pp.37-48, 2004.
DOI : 10.2165/00023210-200418010-00004

P. Lheureux and A. Penaloza, Utilisation et effets secondaires des médicaments administrés pour contrôler l'agitation aiguë et les comportements violents, JEUR, vol.16, pp.199-211, 2003.

J. Calop, B. Allenet, and E. Brudieu, D??finition de la pharmacie clinique, 2008.
DOI : 10.1016/B978-2-294-06234-6.50001-6

V. Tam, S. Knowles, P. Cornish, N. Fine, R. Marchesano et al., Frequency, type and clinical importance of medication history errors at admission to hospital: a systematic review, Canadian Medical Association Journal, vol.173, issue.5, pp.510-515, 2005.
DOI : 10.1503/cmaj.045311

P. Cornish, S. Knowles, R. Marchesano, V. Tam, S. Shadowitz et al., Unintended Medication Discrepancies at the Time of Hospital Admission, Archives of Internal Medicine, vol.165, issue.4, pp.424-429, 2005.
DOI : 10.1001/archinte.165.4.424

H. Autorité and D. Santé, Projet « High 5s ». Communiqué de presse du 10 novembre, 2009.

T. Nester and L. Hale, Effectiveness of a pharmacist-acquired medication history in promoting patient safety, Am J Health Syst Pharm Nov, vol.1559, issue.22, pp.2221-2225, 2002.

C. Bond and C. Raehl, Clinical Pharmacy Services, Pharmacy Staffing, and Hospital Mortality Rates, Pharmacotherapy, vol.58, issue.4, pp.481-493, 2007.
DOI : 10.2146/ajhp050291

J. Hanlon, M. Weinberger, G. Samsa, K. Schmader, K. Uttech et al., A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy, The American Journal of Medicine, vol.100, issue.4, pp.428-437, 1996.
DOI : 10.1016/S0002-9343(97)89519-8

A. Zermansky, D. Alldred, D. Petty, D. Raynor, N. Freemantle et al., Clinical medication review by a pharmacist of elderly people living in care homes--randomised controlled trial, Age and Ageing, vol.35, issue.6, pp.586-591, 2006.
DOI : 10.1093/ageing/afl075

L. Leape, D. Cullen, M. Clapp, E. Burdick, H. Demonaco et al., Pharmacist Participation on Physician Rounds and Adverse Drug Events in the Intensive Care Unit, JAMA, vol.282, issue.3, pp.267-270, 1999.
DOI : 10.1001/jama.282.3.267

S. Kucukarslan, M. Peters, M. Mlynarek, and D. Nafziger, Pharmacists on Rounding Teams Reduce Preventable Adverse Drug Events in Hospital General Medicine Units, Archives of Internal Medicine, vol.163, issue.17, pp.2014-2018, 2003.
DOI : 10.1001/archinte.163.17.2014

A. Guignon, F. Grain, B. Allenet, E. Brudieu, C. Barjhoux et al., Evaluation de l'impact clinique des opinions pharmaceutiques dans un service de médecine spécialisée, J Pharm Clin, vol.20, issue.2, pp.118-141, 2001.

S. Auger, C. Fichter, I. Biajoux, A. Polo, H. Bontemps et al., Audit des prescriptions médicamenteuses en service de gériatrie: Intérêt de la présence d'un pharmacien dans l'unité de soins, La Revue de Gériatrie, vol.24, issue.1, pp.29-38, 1999.

I. Garreau, C. Derharoutunian, E. Kiledjian, S. Mozzon, R. Roubille et al., Pharmacie clinique dans un service de gériatrie : Impacts de la présence pharmaceutique en amont de la prescription, Pharmacie hopitalière française, pp.46-49, 1997.

J. Gurwitz, T. Field, and L. Harrold, Incidence and Preventability of Adverse Drug Events Among Older Persons in the Ambulatory Setting, JAMA, vol.289, issue.9, pp.1107-1116, 2003.
DOI : 10.1001/jama.289.9.1107

D. Fick, J. Cooper, W. Wade, J. Waller, J. Maclean et al., Updating the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults, Archives of Internal Medicine, vol.163, issue.22, pp.2716-2724, 2003.
DOI : 10.1001/archinte.163.22.2716

M. Laroche, F. Bouthier, M. L. Charmes, and J. , M??dicaments potentiellement inappropri??s aux personnes ??g??es??: int??r??t d???une liste adapt??e ?? la pratique m??dicale fran??aise, La Revue de M??decine Interne, vol.30, issue.7, 2009.
DOI : 10.1016/j.revmed.2008.08.010

C. Ryan, O. Mahony, D. Kennedy, J. Weedle, P. Byrne et al., Potentially inappropriate prescribing in an Irish elderly population in primary care, British Journal of Clinical Pharmacology, vol.30, issue.6, pp.936-947, 200912.
DOI : 10.1111/j.1365-2125.2009.03531.x

P. Shekelle, C. Maclean, S. Morton, and N. Wenger, Acove quality indicators, Ann. Intern. Med, vol.135, issue.8 2, pp.653-667, 2001.

D. Lau, J. Kasper, D. Potter, A. Lyles, and R. Bennett, Hospitalization and Death Associated With Potentially Inappropriate Medication Prescriptions Among Elderly Nursing Home Residents, Archives of Internal Medicine, vol.165, issue.1, pp.68-74, 2005.
DOI : 10.1001/archinte.165.1.68

N. Lechevallier-michel, M. Gautier-bertrand, A. Alpérovitch, C. Berr, J. Belmin et al., Frequency and risk factors of potentially inappropriate medication use in a community-dwelling elderly population: results from the 3C Study, European Journal of Clinical Pharmacology, vol.327, issue.3, pp.813-819, 2005.
DOI : 10.1007/s00228-004-0851-z

S. Lee, A. Schwemm, J. Reist, M. Cantrell, M. Andreski et al., Pharmacists' and pharmacy students' ability to identify drug-related problems using TIMER (Tool to Improve Medications in the Elderly via Review), Am J Pharm Educ Mai, vol.2773, issue.3, p.52, 2009.

A. Garg, N. Adhikari, and H. Mcdonald, Effects of Computerized Clinical Decision Support Systems on Practitioner Performance and Patient Outcomes, JAMA, vol.293, issue.10, pp.1223-1238, 20053.
DOI : 10.1001/jama.293.10.1223

A. Spinewine, K. Schmader, N. Barber, C. Hughes, K. Lapane et al., Appropriate prescribing in elderly people: how well can it be measured and optimised?, The Lancet, vol.370, issue.9582, pp.173-184, 2007.
DOI : 10.1016/S0140-6736(07)61091-5

D. Bates, L. Leape, D. Cullen, N. Laird, L. Petersen et al., Effect of Computerized Physician Order Entry and a Team Intervention on Prevention of Serious Medication Errors, JAMA, vol.280, issue.15, pp.1311-1316, 1998.
DOI : 10.1001/jama.280.15.1311

J. Peterson, G. Kuperman, C. Shek, M. Patel, J. Avorn et al., Guided Prescription of Psychotropic Medications for Geriatric Inpatients, Archives of Internal Medicine, vol.165, issue.7, pp.802-807, 2005.
DOI : 10.1001/archinte.165.7.802

J. Avorn, S. Soumerai, D. Everitt, D. Ross-degnan, M. Beers et al., A Randomized Trial of a Program to Reduce the Use of Psychoactive Drugs in Nursing Homes, New England Journal of Medicine, vol.327, issue.3, pp.168-173, 1992.
DOI : 10.1056/NEJM199207163270306

W. Ray, J. Taylor, K. Meador, M. Lichtenstein, M. Griffin et al., Reducing antipsychotic drug use in nursing homes. A controlled trial of provider education, Archives of Internal Medicine, vol.153, issue.6, pp.713-721, 1993.
DOI : 10.1001/archinte.153.6.713

I. Schmidt, C. Claesson, B. Westerholm, L. Nilsson, and B. Svarstad, The Impact of Regular Multidisciplinary Team Interventions on Psychotropic Prescribing in Swedish Nursing Homes, Journal of the American Geriatrics Society, vol.44, issue.Suppl A&B, pp.77-82, 1998.
DOI : 10.1111/j.1532-5415.1998.tb01017.x

V. Camus, R. Gonthier, G. Dubos, P. Schwed, and I. Simeone, Etiologic and Outcome Profiles in Hypoactive and Hyperactive Subtypes of Delirium, Journal of Geriatric Psychiatry and Neurology, vol.56, issue.1, pp.38-42, 2000.
DOI : 10.1177/089198870001300106

G. Bouvenot and P. Villani, Apport des essais pr??-AMM ?? la connaissance du risque iatrog??ne chez la personne ??g??e, Th??rapie, vol.59, issue.2, pp.233-236, 2004.
DOI : 10.2515/therapie:2004045

. Fédération-internationale-pharmaceutique, Déclaration de principe de la FIP : la recherche pharmaceutique auprès des sujets en gériatrie

E. Jano and R. Aparasu, Healthcare Outcomes Associated with Beers' Criteria: A Systematic Review, Annals of Pharmacotherapy, vol.41, issue.3, pp.438-447, 2007.
DOI : 10.1345/aph.1H473

D. Budnitz, N. Shehab, S. Kegler, and C. Richards, Medication Use Leading to Emergency Department Visits for Adverse Drug Events in Older Adults, Annals of Internal Medicine, vol.147, issue.11, pp.755-765, 2007.
DOI : 10.7326/0003-4819-147-11-200712040-00006

M. Laroche, J. Charmes, F. Bouthier, and M. L. , Inappropriate Medications in the Elderly, Clinical Pharmacology & Therapeutics, vol.45, issue.1, pp.94-97, 2008.
DOI : 10.1038/clpt.2008.214

URL : https://hal.archives-ouvertes.fr/hal-00738892

J. Bultel, F. Hemery, M. Gabai, L. Cordier, and V. Fourestié, Prise en charge médicale des états d'agitation dans les services d'accueil et d'urgences -étude rétrospective multicentrique. Actualités en réanimation et urgences, pp.493-510, 1995.

L. Critères-diagnostiques-du and D. , APA) pour le « delirium » dû à une affection médicale générale F05.0 [293.0] : A. Perturbation de la conscience (c'est à dire, baisse d'une prise de conscience claire de l'environnement) avec diminution de la capacité à mobiliser, focaliser

. Remarque, La conception générale du delirium est identique dans le DSM-IV et le CIM-10. Les critères diagnostiques de la CIM-10 comportent des éléments supplémentaires: altération de la mémoire immédiate et des faits récents, avec une relative préservation de la mémoire des faits anciens, désorientation